Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03857373

Renal Cancer Detection Using Convolutional Neural Networks

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Nessn Azawi · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.

Detailed description

We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.

Conditions

Timeline

Start date
2019-02-01
Primary completion
2025-01-01
Completion
2027-01-01
First posted
2019-02-28
Last updated
2024-01-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03857373. Inclusion in this directory is not an endorsement.